Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/WA/Vancouver
Updated October 2026 from ClinicalTrials.gov

Paid Clinical Trials in Vancouver, WA

Studies commonly pay $75 to $4,500 per completed study

1,028 clinical trials are currently recruiting participants within 30 miles of Vancouver. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

1,028studies recruiting
9+research centers nearby
5condition categories
Live from the NIH registry

Studies recruiting near Vancouver right now

Top 25 of 1,028 recruiting studies, sorted by proximity — each links to its official registry page

A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy

Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications Phase 3 Interventional 115 participants sought
Oregon Health and Science University Physicians Pavilion (Adults and Pediatrics) — Portland, Oregon (8.7 mi) · Sponsor: Pierre Fabre Medicament
See eligibility & contact on ClinicalTrials.gov (NCT03394365)

Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer

Endometrial Cancer Phase 2, Phase 3 Interventional 268 participants sought
Northwest Cancer Specialists — Portland, Oregon (8.7 mi) · Sponsor: Kartos Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT05797831)

Sex Differences in Trauma, Inflammation and Brain Function and the Implications for Treatment Efficacy in Alcohol Use Disorder

Alcohol Use Disorder Phase 4 Interventional 100 participants sought
VA Portland Health Care System — Portland, Oregon (8.7 mi) · Sponsor: Milky Kohno
See eligibility & contact on ClinicalTrials.gov (NCT06426303)

Support Via Technology: Living and Learning With Advancing Dementia-REVISED

Caregiver Burden N/A Interventional 238 participants sought
Oregon Health & Science University, Layton Aging and Alzheimer's Disease Research Center — Portland, Oregon (8.7 mi) · Sponsor: Oregon Health and Science University
See eligibility & contact on ClinicalTrials.gov (NCT06460012)

A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients With Operable Non-Small Cell Lung Cancer (NSCLC)

Non-Small Cell Lung Cancer Phase 2 Interventional 120 participants sought
Providence Portland Medical Center — Portland, Oregon (8.7 mi) · Sponsor: Regeneron Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT06465329)

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

PIK3CA Mutation, HER2- Negative Breast Cancer Phase 3 Interventional 540 participants sought
Oregon Health & Science University, Knight Cancer Institute — Portland, Oregon (8.7 mi) · Sponsor: Relay Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06982521)

A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

Colitis, Ulcerative Phase 3 Interventional 882 participants sought
The Oregon Clinic — Portland, Oregon (8.7 mi) · Sponsor: Janssen Research & Development, LLC
See eligibility & contact on ClinicalTrials.gov (NCT07196748)

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

Carcinoma, Transitional Cell, Urinary Bladder Neoplasms Phase 3 Interventional 450 participants sought
Providence Portland Medical Center — Portland, Oregon (8.7 mi) · Sponsor: Eli Lilly and Company
See eligibility & contact on ClinicalTrials.gov (NCT07218380)

LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate Phase 2 Interventional 1,431 participants sought
The Oregon Clinic — Portland, Oregon (8.7 mi) · Sponsor: Eli Lilly and Company
See eligibility & contact on ClinicalTrials.gov (NCT07415044)

OCT Angiography in Wet AMD

Neovascular (Wet) Age-related Macular Degeneration (AMD) N/A Observational 160 participants sought
Casey Eye Institute, Oregon Health & Science University — Portland, Oregon (8.7 mi) · Sponsor: Oregon Health and Science University
See eligibility & contact on ClinicalTrials.gov (NCT02253030)

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Previously Treated Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 10,000 participants sought
PeaceHealth Southwest Medical Center — Vancouver, Washington (3.1 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT03851445)

PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort

Parkinson Disease N/A Observational 4,500 participants sought
Oregon Health &Science University — Portland, Oregon (8.7 mi) · Sponsor: Michael J. Fox Foundation for Parkinson's Research
See eligibility & contact on ClinicalTrials.gov (NCT04477785)

A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

Breast Cancer Phase 3 Interventional 450 participants sought
Providence Portland Medical Center — Portland, Oregon (8.7 mi) · Sponsor: Hoffmann-La Roche
See eligibility & contact on ClinicalTrials.gov (NCT06790693)

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma Phase 2 Interventional 40 participants sought
Ohio State University-Telemedicine — Portland, Oregon (8.7 mi) · Sponsor: Sameek Roychowdhury
See eligibility & contact on ClinicalTrials.gov (NCT06906562)

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

Chronic Obstructive Pulmonary Disease Phase 3 Interventional 942 participants sought
The Oregon Clinic - Portland - Northwest 22nd Avenue- Site Number : 8400065 — Portland, Oregon (8.7 mi) · Sponsor: Sanofi
See eligibility & contact on ClinicalTrials.gov (NCT07190222)

A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults

Chronic Idiopathic Constipation (CIC) Phase 3 Interventional 692 participants sought
Advanced Research Institute - Portland — Tigard, Oregon (16.5 mi) · Sponsor: Ardelyx
See eligibility & contact on ClinicalTrials.gov (NCT07382167)

Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry

Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease N/A Observational 3,000 participants sought
Oregon Clinic — Portland, Oregon (8.7 mi) · Sponsor: Duke University
See eligibility & contact on ClinicalTrials.gov (NCT01915511)

Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)

Spinal Muscular Atrophy (SMA) N/A Observational 700 participants sought
Oregon Health and Science University — Portland, Oregon (8.7 mi) · Sponsor: Novartis Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT04174157)

Vitamin C to Decrease Effects of Smoking in Pregnancy on Infant Lung Function (VCSIP) Longer Term Follow Up

Asthma, Pulmonary Function N/A Observational 225 participants sought
Oregon Health and Science University (OHSU) — Portland, Oregon (8.7 mi) · Sponsor: Oregon Health and Science University
See eligibility & contact on ClinicalTrials.gov (NCT06106646)

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

Non-Small Cell Lung Cancer Phase 3 Interventional 675 participants sought
Research Site — Vancouver, Washington (3.1 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06357533)

Quantification & Classification of Inflammatory Cells in Uveitis Using OCT

Anterior Uveitis (AU), Birdshot Chorioretinitis N/A Observational 125 participants sought
Casey Eye Institute - Oregon Health & Science University — Portland, Oregon (8.7 mi) · Sponsor: Oregon Health and Science University
See eligibility & contact on ClinicalTrials.gov (NCT07065747)
Actively enrolling

Studies you may be able to join near Vancouver

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

See which clinical studies you may qualify for

A partner research network matches volunteers with studies that are currently enrolling in the United States. You answer a few screening questions about your health and where you live; if a study looks like a fit, its team contacts you to confirm eligibility.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Vancouver

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Oregon Medical Research Center

★ 4.4
1750 S Harbor Way Unit 330, Portland, OR 97201
(503) 245-1525
"Fantastic start to finish. The Staff at OMRC were kind, professional, helpful, informative, and were the first healthcare providers to believe me and…"
— Amy Pettinger, 5★

Legacy Research Institute

★ 4.4
1225 NE 2nd Ave, Portland, OR 97232
(503) 413-2491
"Safe place to get help, PES is a little uncomfortable but they get you a bed as fast as they can and the nurses are almost all nice"
— Lukas, 4★

Summit Research Network Oregon, Inc.

★ 4.6
2701 NW Vaughn St #350, Portland, OR 97210
(503) 279-8252
"The entire staff from the front dest to the lab lady's, doctors, and medical assistants are extremely compationate and friendly."
— Valerie Carter, 5★

Verity Health PNW

★ 5.0
3250 SE 164th Ave Ste 205, Vancouver, WA 98683
(360) 946-4313
"Knowledgeable, friendly, efficient"
— partlybohunk, 5★

Northwest Research Center

★ 5.0
6327 SE Milwaukie Ave, Portland, OR 97202
(503) 238-6233

Kaiser Permanente Center for Health Research

★ 3.4
3800 N Interstate Ave, Portland, OR 97227
(503) 335-2400
"So far, so good! Most professionals seems to be genuinely friendly."
— Luciano De Lopes, 5★

OHSU Mark O. Hatfield Research Center

★ 3.8
Hatfield Research Center, 3181 SW Sam Jackson Park Rd, Portland, OR 97239
"Doctors, surgeons, faculty, everyone is wonderful & top-of-their-game qualified."
— Robin Knauerhase, 5★

Providence Center for Outcomes Research and Education - Portland

★ 5.0
4400 NE Halsey St Bldg 1, Suite 265, Portland, OR 97213
(503) 215-7170

Advanced Research Institute-Portland

★ 5.0
13200 SW Pacific Hwy, Portland, OR 97223
(503) 610-0033
"My expriance is great all the time."
— chris Gonzalez, 5★

Clinical trials in Vancouver: what's recruiting

The Vancouver area currently has 1,028 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Vancouver, the most active research areas are:

  • Cancer & Oncology9 studies
  • Immune & Skin3 studies
  • Lungs & Breathing3 studies
  • Heart & Vascular1 studies
  • Brain & Mental Health1 studies

Every listing shows the study phase, the recruiting site and its distance from Vancouver, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Vancouver

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Vancouver participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Vancouver pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
How do I join a study in Vancouver, WA?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
What is the difference between a research center and a hospital study in Vancouver?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
How often do new paid studies open in Vancouver?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Vancouver.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Vancouver typically complete one or two studies per year.

Paid clinical trials near Vancouver

Other metros within reach

Portland, OR1,028 Salem, OR110 Olympia, WA227 Tacoma, WA1,459 Eugene, OR144 Bremerton, WA1,479 Seattle, WA1,507 Bellevue, WA1,514

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Vancouver Bladder Issues Due To Spinal Cord Injury in Vancouver All conditions

More of WA

Bellevue1,514 Seattle1,507 Bremerton1,479 Tacoma1,459 Spokane293 Olympia227 Marysville202 Kennewick54

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts